Actively Recruiting
Evaluating the Safety and Effectiveness of the Cytrellis Micro-Coring Device for Treating Moderate to Severe Facial Wrinkles in Adults Aged 40 to 70
Led by Cytrellis Biosystems, Inc. · Updated on 2019-01-04
35
Participants Needed
6
Research Sites
9 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the Cytrellis Micro-Coring Device for treating moderate to severe wrinkles on the face, specifically focusing on the cheeks and neck areas. This study involves up to 35 adults aged 40 to 70 years with Fitzpatrick Skin Types I to IV. The goal is to improve skin appearance by reducing wrinkle severity using this novel device. Participants will undergo one treatment session using the micro-coring device, which removes small sections of skin on the face and neck. Following this treatment, participants will be monitored closely for 90 days to assess changes and any side effects. The study includes various methods to evaluate wrinkle improvement, such as the Lemperle Wrinkle Severity Scale and other aesthetic improvement scales. During the study, participants will have scheduled assessments to measure wrinkle severity and satisfaction with treatment results. Safety monitoring will include recording any adverse events immediately after treatment and at several follow-up visits up to 90 days later. Participants will also complete a diary for two weeks post-treatment to track any side effects. The total involvement period for each participant is approximately three months.
CONDITIONS
Brief Title
Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here